Kocab, A.J.; Cano, M.; Bacellar-Galdino, M.; Jamison, J.A.; Brock, W.J.; Zacks, D.N.; Handa, J.T.
In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration. Biomedicines 2025, 13, 2052.
https://doi.org/10.3390/biomedicines13092052
AMA Style
Kocab AJ, Cano M, Bacellar-Galdino M, Jamison JA, Brock WJ, Zacks DN, Handa JT.
In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration. Biomedicines. 2025; 13(9):2052.
https://doi.org/10.3390/biomedicines13092052
Chicago/Turabian Style
Kocab, Andrew J., Marisol Cano, Marianna Bacellar-Galdino, Jeffrey A. Jamison, William J. Brock, David N. Zacks, and James T. Handa.
2025. "In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration" Biomedicines 13, no. 9: 2052.
https://doi.org/10.3390/biomedicines13092052
APA Style
Kocab, A. J., Cano, M., Bacellar-Galdino, M., Jamison, J. A., Brock, W. J., Zacks, D. N., & Handa, J. T.
(2025). In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration. Biomedicines, 13(9), 2052.
https://doi.org/10.3390/biomedicines13092052
